JPMORGAN CHASE & CO - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 45 filers reported holding THERAPEUTICSMD INC in Q3 2022. The put-call ratio across all filers is 2.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2023$945
-26.7%
3130.0%0.00%
Q2 2023$1,289
+8.5%
313
-13.8%
0.00%
Q1 2023$1,188
+59300.0%
363
-23.7%
0.00%
Q4 2022$2
-99.9%
476
+52.1%
0.00%
Q3 2022$2,000
-50.0%
313
-6.8%
0.00%
Q2 2022$4,0003360.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 1,156,953$7,682,0000.39%
SANDERS MORRIS HARRIS LLC 40,393$268,0000.07%
XR Securities LLC 41,200$63,0000.03%
State of Wyoming 8,797$58,0000.03%
J. Goldman & Co LP 82,976$551,0000.03%
Asset Management Group, Inc. 14,701$98,0000.02%
EQUITEC PROPRIETARY MARKETS, LLC 12,000$80,0000.02%
EQUITEC PROPRIETARY MARKETS, LLC 9,100$60,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 38,042$253,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 15,000$100,0000.00%
View complete list of THERAPEUTICSMD INC shareholders